Ono Pharmaceutical Co., Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ON4.MU | REC.MI | YPH.F | OGN | 4552.T | 1093.HK | |
|---|---|---|---|---|---|---|
| Market cap | 6.49B | 11.01B | 24.92B | 3.61B | 64.91B | 99.23B |
| P/E (TTM) | 15.3 | 22.2 | 12.3 | 17.6 | 79.4 | 11.9 |
| Forward P/E | — | 14.0 | — | 3.8 | 14.5 | 13.0 |
| Price/book | 1.3 | 5.1 | 2.3 | 3.6 | 1.5 | 2.2 |
| Dividend yield | 3.30% | 2.68% | 3.28% | 0.58% | 3.83% | 4.04% |
| 1-year change | +34.07% | +2.91% | +55.58% | +53.91% | −16.35% | +5.44% |
| Today | +0.99% | −0.09% | +1.46% | −0.04% | +1.92% | −2.47% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All ON4.MU news ›Ono Pharmaceutical (OTCMKTS:OPHLF) Stock Crosses Above Fifty Day Moving Average – Should You Sell?
Posted by Tristan Rich on Oct 18th, 2026 Ono Pharmaceutical Co. (OTCMKTS:OPHLF – Get Free Report)’s share price crossed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $15.09 and…
Biohaven Licenses IgG Degrader Portfolio to Ono Pharmaceutical for $80M Upfront, 20% Royalties
TradingView Biohaven Licenses IgG Degrader Portfolio to Ono Pharmaceutical for $80M Upfront, 20% Royalties Biohaven entered into a Collaboration and License Agreement with Ono Pharmaceutical to develop and commercialize its MoDE pan IgG…
Ono Pharmaceutical Co., Ltd. : Insider Transactions
Follow insider transactions on Ono Pharmaceutical Co., Ltd. in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Ono Pharmaceutical Co., Ltd. Latest insider transactions for…
Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1
Ono Pharmaceutical posted profit attributable to owners of the company of 24.2 billion yen for the fiscal first quarter, up 37% from 17.7 billion yen a year earlier, according to a Friday exchange... Ono Pharmaceutical Co., Ltd. Ono…
Ono Pharmaceutical Co., Ltd.: Official Announcements - Stock Market News
Find the latest press releases and official documents published by Ono Pharmaceutical Co., Ltd. on MarketScreener. Press Releases Ono Pharmaceutical Co., Ltd. All financial news and data tailored to specific country editions
Ono Pharmaceutical Co., Ltd. Stock (4528) - Quote Japan Exchange
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused…
Ono Pharmaceutical's Attributable Profit Jumps 39% in Fiscal Year 2025
Ono Pharmaceutical's profit attributable to owners of the parent for fiscal year 2025 climbed 39% to 69.8 billion yen from 50 billion yen a year earlier. The pharmaceutical company's earnings per... Ono Pharmaceutical Co., Ltd. Ono…
Ono Pharmaceutical Secures Asian Rights to Biohaven's Autoimmune Drugs
www.marketscreener.com Ono Pharmaceutical Co., Ltd. Ono Pharmaceutical Secures Asian Rights to Biohaven's Autoimmune Drugs Published on 10/08/2026 at 10:55 pm EDT
Ono Pharmaceutical Co., Ltd.: Latest Headlines - Japan Exchange Stock Exchange
Find the latest highlights on Ono Pharmaceutical Co., Ltd. at the Japan Exchange stock exchange. Highlights Ono Pharmaceutical Co., Ltd. All financial news and data tailored to specific country editions
Ono Pharmaceutical Co., Ltd.: News in other languages | 4528 | JP3197600004
Ono Pharmaceutical Co., Ltd.: News, information and stories for Ono Pharmaceutical Co., Ltd. | Japan Exchange: 4528 | Japan Exchange Other languages Ono Pharmaceutical Co., Ltd. All financial news and data tailored to specific country…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com18
-
themarketsdaily.com1
-
tradingview.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 20 articles, not a forecast.